michigan hypertension core curriculum - State of Michigan

More documents

Recommendations

Info

Table 2 Table 3 Screening Test for CKD Estimation of GFR Age, weight and plasma creatinine for Cockroft-Gault Age, race, gender and plasma creatinine for MDRD Age, height, gender and plasma creatinine for Schwartz Evaluation of the urine Urinalysis Dipstick for protein, blood, glucose Microalbumin or protein/creatinine ratio Radiologic Imaging Renal ultrasound with doppler Cockroft-Gault = http://www.clinicalculator.com/english/nephrology/cockroft Modification of diet in renal disease (MDRD) = http://www.mdrd.com Schwartz = http://www.kidney.org/professionals/kdoqi/gfr_calculatorPed.cfm Table 4 STAGE DESCRIPTION =Kidney damage with… GFR (ml/min/1.73m2) 1 normal or increased GFR > 90 2 mild decrease in GFR 60-89 3 moderate decrease in GFR 30-59 4 severe decrease in GFR 15-29 5 kidney failure
Figure 1: Causes of ESRD. USRDS 2008 Annual Data Report Figure 2: Distribution of Systolic Blood Pressure (mmHg) among Adults with CKD in NHANES IV. Peralta et al. Hypertension 2005 ; 45 ; 1119-1124 NKFM & MDCH 47
Page 1: MICHIGAN HYPERTENSION CORE CURRICUL
Page 4 and 5: April 2010 Dear Colleague: In 2005,
Page 6 and 7: Kevin L. Piggott, MD, MPH, FAAFP Pr
Page 8 and 9: Blood Pressure Measurement........
Page 10 and 11: 10 Hypertension Core Curriculum Blo
Page 12 and 13: of the wrist. Additionally, there i
Page 14 and 15: asis. National guidelines recommend
Page 16 and 17: Post-Test Questions: 1. High BP is
Page 18 and 19: 18 Hypertension Core Curriculum Ess
Page 20 and 21: Masked Hypertension is when the off
Page 22 and 23: TABLE 1. Prevalence of Awareness, T
Page 24 and 25: Blood Pressure, Circulatory Physiol
Page 26 and 27: side of the vascular tree. Arterial
Page 28 and 29: upon the other co-morbidities prese
Page 30 and 31: Table 3. Clinically Available Clues
Page 32 and 33: In the setting of chronic hypertens
Page 34 and 35: 34 Hypertension Core Curriculum Tab
Page 36 and 37: cause greater disruption of CBF aut
Page 38 and 39: References/Suggested Reading Agabit
Page 40 and 41: 40 Hypertension Core Curriculum Chr
Page 42 and 43: development of essential HTN can se
Page 44 and 45: Figures: Figure 1. Pie-chart with m
Page 48 and 49: References: 1. U.S. Renal Data Syst
Page 50 and 51: 50 Hypertension Core Curriculum Spe
Page 52 and 53: side effects particularly well. A h
Page 54 and 55: 14. Gaede P, Vedel P, Larsen N, Jen
Page 56 and 57: Learning Objectives: 56 Hypertensio
Page 58 and 59: glycemic risk factdors such as hype
Page 60 and 61: . Weight loss c. Weight gain d. A a
Page 62 and 63: References: 1. Association AD. All
Page 64 and 65: 64 Hypertension Core Curriculum Spe
Page 66 and 67: foods and turn out of necessity to
Page 68 and 69: Figure 1: Table 1. Metabolic Syndro
Page 70 and 71: 9. Singh GK, Kogan MD, Van Dyck PC,
Page 72 and 73: Incidence and Prevalence The overal
Page 74 and 75: access to healthy foods than their
Page 76 and 77: As a part of the approach to managi
Page 78 and 79: B Hypertensive Adults (rate, percen
Page 80 and 81: References: 1. Lewington S, Clarke
Page 82 and 83: 82 Hypertension Core Curriculum
Page 84 and 85: appear to be related to access to c
Page 86 and 87: CDC MMWR Feb 24, 2006/55(07); 177-1
Page 88 and 89: Figure 1; Clinical presentation and
Page 90 and 91: 90 Hypertension Core Curriculum Phe
Page 92 and 93: ANY patient, who develops paroxysma
Page 94 and 95: Figure 1: 94 Hypertension Core Curr
Page 96 and 97:
Objectives: 96 Hypertension Core Cu
Page 98 and 99:
Definition Prevalence Clinical Feat
Page 100 and 101:
intake. 4 Figure 1; Ion transport i
Page 102 and 103:
loading with 200 mmoles (4.6 grams)
Page 104 and 105:
Figure 3; Endocrine Society See tex
Page 106 and 107:
INTRODUCTION 106 Hypertension Core
Page 108 and 109:
Renal manifestations. Renal ischemi
Page 110 and 111:
to assess renal dimensions and dupl
Page 112 and 113:
stenosis severity. Patients with no
Page 114 and 115:
ARAS, ischemic nephropathy, and imp
Page 116 and 117:
the goals of minimizing injury to t
Page 118 and 119:
hemodynamically impaired renal arte
Page 120 and 121:
e classified as having “renovascu
Page 122 and 123:
disease of the abdominal aorta and
Page 124 and 125:
Table 1. Contemporary evaluation of
Page 126 and 127:
2. Screening tests for RAS RDU, MRA
Page 128 and 129:
Manifestations of vital organ injur
Page 130 and 131:
Table 6. Clinical evaluation of ren
Page 132 and 133:
Table 9. Assessment of worsening re
Page 134 and 135:
Table 11. New terminology for renal
Page 136 and 137:
References: 1. Murphy TP, Soares G,
Page 138 and 139:
2001;12(6):1235-1241. 40. Subramani
Page 140 and 141:
78. Tami LF, McElderry MW, al-Adli
Page 142 and 143:
142 Hypertension Core Curriculum Pr
Page 144 and 145:
monitored hypertension screening an
Page 146 and 147:
Policy Development: Public health p
Page 148 and 149:
Med Clin North Am. Jan 2004;88(1):2
Page 150 and 151:
mind they will have no problem iden
Page 152 and 153:
Role of Race in the Selection of An
Page 154 and 155:
individuals of any race or ethnicit
Page 156 and 157:
Older Patients Need Elevated Systol
Page 158 and 159:
sister, mother and father. A family
Page 160 and 161:
ecause pressure-related retinopathy
Page 162 and 163:
pulses (lower in the left arm). 4 C
Page 164 and 165:
Vital signs suggestive of OSAHS. 20
Page 166 and 167:
may shed light on underlying medica
Page 168 and 169:
References: patients. 8 However, th
Page 170 and 171:
Objectives: 170 Hypertension Core C
Page 172 and 173:
and evidence that anti-hypertensive
Page 174 and 175:
When subjects are given instruction
Page 176 and 177:
interestingly found only a 6.0/4.6
Page 178 and 179:
pressure: a meta-analysis of random
Page 180 and 181:
isolated systolic hypertension have
Page 182 and 183:
Compelling Indications for Specific
Page 184 and 185:
3.) Beta-blockers, ACE inhibitors,
Page 186 and 187:
treatment levels - albeit though at
Page 188 and 189:
Preparations and Dosage: Oral antih
Page 190 and 191:
Preparations and Dosages: The Oral
Page 192 and 193:
patients with tachy-brady syndrome
Page 194 and 195:
significant proteinuria. Pharmacolo
Page 196 and 197:
the effect found by the ACE inhibit
Page 198 and 199:
and nominally statistically signifi
Page 200 and 201:
sensitive K+-channels in vascular s
Page 202 and 203:
clonidine (Catapres†) 0.1-0.8 mg
Page 204 and 205:
Learning Objectives 204 Hypertensio
Page 206 and 207:
general, the response to beta-block
Page 208 and 209:
Table 2: (JNC VII, 2004) 208 Hypert
Page 210 and 211:
Learning objectives: 210 Hypertensi
Page 212 and 213:
ecently published RCT investigated
Page 214 and 215:
Post-test question: 35y/o male w/ h
Page 216 and 217:
Orthostatic Hypotension Pretest que
Page 218 and 219:
BP. It is important to note that la
Page 220 and 221:
1- Fludrocortisone : a mineralocort
Page 222 and 223:
References: 1. Hiitola P, Enlund H,
Page 224 and 225:
www.neuroanatomy.wisc.edu/.../Image
Page 226 and 227:
Learning objectives: 226 Hypertensi
Page 228 and 229:
controlled BP to have been victimiz
Page 230 and 231:
Treatment of Secondary Causes of Hy
Page 232 and 233:
4-Direct vasodilators (e.g.minoxidi
Page 234 and 235:
Hypertension. Aug 2003;42(2):161-16
Page 236 and 237:
emergency by virtue of the associat
Page 238 and 239:
PATHOPHYSIOLOGY The underlying mech
Page 240 and 241:
trials included a placebo arm. Seve
Page 242 and 243:
an indication for careful and modes
Page 244 and 245:
ACUTE KIDNEY INJURY (AKI) In additi
Page 246 and 247:
Blood Pressure Research Council, an
Page 248 and 249:
[ACE inhibitors (ACEIs), angiotensi
Page 250 and 251:
y sodium restriction or the use of
Page 252 and 253:
44 months 24 , and were also seen i
Page 254 and 255:
• Hypertension in dialysis patien
Page 256 and 257:
GISEN Group (Gruppo Italiano di Stu
Page 258 and 259:
258 Hypertension Core Curriculum
Page 260 and 261:
DEFINITION AND CLASSIFICATION Hyper
Page 262 and 263:
etween adult socioeconomic position
Page 264 and 265:
women treated with atenolol in earl
Page 266 and 267:
Obstet Gynecol. Dec 12 2008. 5. Vol
Page 268 and 269:
able to dissipate the pressure rise
Page 270 and 271:
Use of Dihydropyridine Calcium Anta
Page 272 and 273:
272 Hypertension Core Curriculum Ca
Page 274 and 275:
Case 4 Hypertensive patient with CK
Page 276 and 277:
Case 6 276 Hypertension Core Curric
Page 278 and 279:
year. Sodium restriction and weight
Page 280:
What may be causing these new sympt
show all

michigan hypertension core curriculum - State of Michigan

Create successful ePaper yourself

Delete template?

Save as template?